Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants-Reference-Cited by-同舟云学术

Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants

Published:2014-07 Issue:33 Volume:32 Page:4111-4116
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Rubsamen R.M.,Herst C.V.,Lloyd P.M.,Heckerman D.E.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Immunology and the elusive AIDS vaccine;Virgin;Nature,2010

2. Design and pre-clinical evaluation of a universal HIV-1 vaccine;Létourneau;PLoS One,2007

3. HIV-1 group M conserved elements vaccine;Rolland;PLoS Pathog,2007

4. Canvassing CROI. IAVI Report;Kresge,2009

5. Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype;Dinges;J Virol,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Vaccine Therapy for Triple-Negative Breast Cancer;Current Breast Cancer Reports;2024-05-08

2. Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine;Vaccines;2024-03-18

3. Progress in Treatment and Diagnostics of Infectious Disease with Polymers;ACS Infectious Diseases;2024-01-18

4. Antiviral drug carriers for human immunodeficiency virus;Nano Trends;2023-12

5. Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study;Vaccines;2023-03-13